Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» migraines
migraines
Alder BioPharmaceuticals approaches rare status for a Seattle biotech
Bizjournals
Sat, 08/17/19 - 01:33 pm
Alder Biopharmaceuticals
Seattle
migraines
Racing after the leaders, Eli Lilly's migraine drug clears another pivotal study
Endpoints
Mon, 08/5/19 - 10:59 am
Eli Lilly
Emgality
clinical trials
migraines
chronic migraine
episodic migraine
Lilly's Emgality powers ahead with 'best-in-class' CGRP access
Fierce Pharma
Tue, 07/30/19 - 04:21 pm
Eli Lilly
Emgality
migraines
Amgen
Aimovig
Teva Pharmaceutical
Ajovy
Migraine patient or doctor? Demand more, Biohaven advises in new awareness push
Fierce Pharma
Tue, 07/16/19 - 11:06 pm
Biohaven
patients
migraines
pharma marketing
Emgality-maker Lilly courts payers with new migraine ER data
Fierce Pharma
Fri, 07/12/19 - 12:22 pm
Eli Lilly
Emgality
cluster headache
migraines
Amgen
Novartis
Teva Pharmaceutical
ER
Biohaven, sporting new data, moves closer to CGRP finish line—and maybe M&A
Fierce Pharma
Fri, 07/12/19 - 09:50 am
Biohaven
migraines
CGRP blockers
rimegepant
How can Teva's migraine drug face off Amgen and Lilly? Put neurologists first, DTC last, executive says
Fierce Pharma
Tue, 05/14/19 - 04:55 pm
Teva Pharmaceutical
migraines
Ajovy
Amgen
Eli Lilly
Emgality
Aimovig
neurologists
physicians
DTC advertising
Lilly's new migraine drug pulls ahead of Amgen in fierce battle for new prescriptions
Yahoo/Reuters
Sat, 05/11/19 - 12:10 pm
Eli Lilly
Amgen
Teva Pharmaceutical
migraines
Emgality
Aimovig
Eli Lilly's Emgality shows positive Phase 3 results in treatment of migraine
Pharmafile
Wed, 05/8/19 - 05:39 pm
Eli Lilly
migraines
clinical trials
Emgality
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
Xconomy
Sat, 05/4/19 - 04:54 pm
migraines
CGRP blockers
Aimovig
Amgen
Ajovy
Teva Pharmaceutical
Emgality
Eli Lilly
Faint hope for Alder as Teva bucks dismal migraine trend
EP Vantage
Thu, 05/2/19 - 11:12 am
migraines
Alder Biopharmaceuticals
Teva
Eli Lilly
Amgen
Emgality
Ajovy
eptinezumab
Why Satsuma investors see room for another migraine therapy
BioCentury
Wed, 04/24/19 - 10:38 pm
Satsuma Pharmaceuticals
migraines
STS101
clinical trials
FDA accepts BLA for Alder's migraine therapy for infusion
BioCentury
Mon, 04/22/19 - 06:59 pm
Alder Biopharma
FDA
eptinezumab
migraines
Why Alder thinks its late-comer migraine drug can succeed
Biopharma Dive
Thu, 04/11/19 - 12:28 pm
Alder Biopharmaceuticals
migraines
eptinezumab
Scotland backs Aimovig for migraine after NICE says no
Pharmaforum
Tue, 04/9/19 - 08:20 am
Scotland
NICE
migraines
Aimovig
Amgen
Novartis
Lawsuit over migraine deal could be good for Amgen, analysts say
Marketwatch
Sat, 04/6/19 - 02:09 pm
Novartis
Amgen
migraines
Aimovig
Amgen and Novartis file dueling lawsuits over their deal to market a migraine drug
Stat
Thu, 04/4/19 - 11:22 pm
Novartis
Amgen
Aimovig
migraines
Novartis sues Amgen over migraine treatment Aimovig
Yahoo/Reuters
Thu, 04/4/19 - 12:04 pm
Novartis
Amgen
Aimovig
migraines
Teva wins EU nod for Ajovy migraine prophylactic
Drug Delivery Business News
Tue, 04/2/19 - 04:25 pm
Teva Pharmaceutical
Europe
migraines
Ajovy
Theranica raises $35m Series B for neuromod migraine patch
Mass Device
Tue, 03/19/19 - 08:17 pm
Theranica Bio-Electronics
Nerivio Migra neurostem patch
devices
migraines
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »